Leyre Mestre

Madrid, MD 28002, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

The Dual PDE7-GSK3β Inhibitor, VP3.15, as Neuroprotective Disease-Modifying Treatment in a Model of Primary Progressive Multiple Sclerosis.

The Dual PDE7-GSK3β Inhibitor, VP3.15, as Neuroprotective Disease-Modifying Treatment in a Model of Primary Progressive Multiple Sclerosis.

Journal: International journal of molecular sciences

Published: October 04, 2022

Efficacy of Vafidemstat in Experimental Autoimmune Encephalomyelitis Highlights the KDM1A/RCOR1/HDAC Epigenetic Axis in Multiple Sclerosis.

Efficacy of Vafidemstat in Experimental Autoimmune Encephalomyelitis Highlights the KDM1A/RCOR1/HDAC Epigenetic Axis in Multiple Sclerosis.

Journal: Pharmaceutics

Published: June 03, 2022

Selected Clostridia Strains from The Human Microbiota and their Metabolite, Butyrate, Improve Experimental Autoimmune Encephalomyelitis.

Selected Clostridia Strains from The Human Microbiota and their Metabolite, Butyrate, Improve Experimental Autoimmune Encephalomyelitis.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: January 26, 2021

Aging and neuroinflammation: Changes in immune cell responses, axon integrity, and motor function in a viral model of progressive multiple sclerosis.

Aging and neuroinflammation: Changes in immune cell responses, axon integrity, and motor function in a viral model of progressive multiple sclerosis.

Journal: Aging cell

Published: January 18, 2021

How oral probiotics affect the severity of an experimental model of progressive multiple sclerosis? Bringing commensal bacteria into the neurodegenerative process.

How oral probiotics affect the severity of an experimental model of progressive multiple sclerosis? Bringing commensal bacteria into the neurodegenerative process.

Journal: Gut microbes

Published: September 09, 2020

Effects of EHP-101 on inflammation and remyelination in murine models of Multiple sclerosis.

Effects of EHP-101 on inflammation and remyelination in murine models of Multiple sclerosis.

Journal: Neurobiology of disease

Published: March 27, 2020

A Commercial Probiotic Induces Tolerogenic and Reduces Pathogenic Responses in Experimental Autoimmune Encephalomyelitis.

A Commercial Probiotic Induces Tolerogenic and Reduces Pathogenic Responses in Experimental Autoimmune Encephalomyelitis.

Journal: Cells

Published: March 12, 2020

Involvement of Wnt7a in the role of M2c microglia in neural stem cell oligodendrogenesis.

Involvement of Wnt7a in the role of M2c microglia in neural stem cell oligodendrogenesis.

Journal: Journal of neuroinflammation

Published: December 11, 2019

Perspectives on Cannabis-Based Therapy of Multiple Sclerosis: A Mini-Review.

Perspectives on Cannabis-Based Therapy of Multiple Sclerosis: A Mini-Review.

Journal: Frontiers in cellular neuroscience

Published: October 30, 2019

2-arachidonoylglycerol reduces chondroitin sulphate proteoglycan production by astrocytes and enhances oligodendrocyte differentiation under inhibitory conditions.

2-arachidonoylglycerol reduces chondroitin sulphate proteoglycan production by astrocytes and enhances oligodendrocyte differentiation under inhibitory conditions.

Journal: Glia

Published: June 19, 2019

Manipulation of Gut Microbiota Influences Immune Responses, Axon Preservation, and Motor Disability in a Model of Progressive Multiple Sclerosis.

Manipulation of Gut Microbiota Influences Immune Responses, Axon Preservation, and Motor Disability in a Model of Progressive Multiple Sclerosis.

Journal: Frontiers in immunology

Published: April 02, 2019

The endocannabinoid 2-AG enhances spontaneous remyelination by targeting microglia.

The endocannabinoid 2-AG enhances spontaneous remyelination by targeting microglia.

Journal: Brain, behavior, and immunity

Published: June 26, 2018

Showing 1-12 of 30

Last Updated: 09/26/2026